Pharmacogenetic investigation of pyrexia in patients treated with dabrafenib alone or in combination with trametinib from five melanoma studies von Kulkarni, Diptee A, Song, Kijoung, Briley, Linda P, King, Karen S, Dabrowski, Christine Ellen, Del Buono, Heather Lynn, Mookerjee, Bijoyesh, Legos, Jeffrey J., Spraggs, Colin F.

Volltext

Updated overall survival (OS) results for BRF113220, a phase I–II study of dabrafenib alone versus combined dabrafenib and trametinib in patients with BRAF V600 metastatic melanoma... von Daud, Adil, Weber, Jeffrey S., Sosman, Jeffrey Alan, Kim, Kevin, Gonzalez, Rene, Hamid, Omid, Infante, Jeffrey R., Cebon, Jonathan S., Schuchter, Lynn Mara, Long, Georgina V., Algazi, Alain Patrick, Kudchadkar, Ragini Reiney, Puzanov, Igor, Lawrence, Donald P., Kefford, Richard, Kline, Amy S., Del Buono, Heather Lynn, Sun, Peng, McDowell, Diane Opatt, Flaherty, Keith

Volltext